抗血栓剂周内镜管理中的当代方法:当前的范式,挑战和预测
Jiaxuan Zuo1,2, Wei Jiang1,2, Lumei Wang1,2
1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University State Key Laboratory of Digestive Health National Clinical Research Center for Digestive Disease.
Therapeutic advances in gastroenterology
|June 30, 2025
概括
在内镜手术期间管理抗血栓剂是具有挑战性的,因为不一致的准则遵守. 加强教育和数字工具等策略可以提高患者的安全性,减少并发症.
科学领域:
- 胃肠病学 胃肠病学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对抗血栓性药物的周内镜管理存在挑战.
- 全球范围内普遍存在不一致的遵守既定指南.
- 这会影响患者的安全,增加血栓栓塞和出血事件的风险.
研究的目的:
- 审查在内镜手术中抗血栓治疗中遵守次优指南的障碍.
- 提出改善合规性和标准化患者护理的策略.
- 强调需要协调国际指导方针和资源分配.
主要方法:
- 关于抗血栓治疗管理现有指南和研究的文献综述.
- 分析障碍,包括教育,指导方针更新,责任,成本和资源分配.
- 综合拟议的战略,以提高合规性和患者安全.
主要成果:
- 确定了关键障碍:教育不足,指导方针更新延迟,责任不清楚,成本差异和资源分配不均.
- 拟议的战略包括加强教育,数字临床决策辅助工具,统一管理团队和国际合作.
- 在实践中存在全球差异,与不同的战法林戒断协议 (例如,中国与西方国家).
结论:
- 改善对抗血栓管理指南的遵守对于内镜期间的患者安全至关重要.
- 需要多方面的战略,包括教育,技术,以团队为基础的护理和国际协调.
- 未来的方向包括人工智能和远程医疗,用于个性化风险评估和决策支持.
相关概念视频
Venous Thrombosis III: Interprofessional Care
27
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
27
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
653
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
653
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
47
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
47
Peripheral Artery Disease III: Interprofessional Care
33
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
33
Anticoagulant Drugs: Low-Molecular-Weight Heparins
921
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
921


